SARS CTL vaccine candidates; HLA supertype‐, genome‐wide scanning and biochemical validation

Abstract excerpt

An effective Severe Acute Respiratory Syndrome (SARS) vaccine is likely to include components that can induce specific cytotoxic T-lymphocyte (CTL) responses. The specificities of such responses are governed by human leukocyte antigen (HLA)-restricted presentation of SARS-derived peptide epitopes. Exact knowledge of how the immune system handles protein antigens would allow for the identification of such linear...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Immunotherapy and Immune Responses
• Share to SARS-CoV-2 and COVID-19 Research
• Share to vaccines and immunoinformatics approaches